Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02242968 · ClinicalTrials.gov registry record
Screening of Volunteers for Clinical Trials of Investigational or Licensed Vaccines or Antiviral Products
A clinical trial, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- 9
- Enrollment target
NCT02242968: Completed study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
NCT02242968 is a clinical trial that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 9 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02242968 has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- 9 participants
- Enrollment target
Study Summary
Background: \- Vaccines and antiviral therapies help prevent and treat diseases. Researchers need a group of healthy volunteers for clinical trials. Clinical trials are studies that test these vaccines and therapies in people. Objective: \- To screen volunteers for clinical trials for investigational or licensed vaccines or drugs to treat or prevent virus infections. Eligibility: \- Healthy adults age 18 or older. Design: * Participants will be asked questions about their health history, including sexual activity and drug use. They will give blood samples. They may have a physical exam. They may give a urine sample. * Participants may have the inside of their nose either swabbed or washed with some fluid. The fluid will be collected. They may give a stool sample. * Participants may have an electrocardiogram. Soft, sticky patches will be attached to participants chest, arms, and legs. They will lie still on a table while the patches detect the heart s electrical signals. A machine will record these signals. * Participants may have lung function tests. These tests measure the volume of air moving in and out of the lungs. Participants will forcibly blow air into a machine. * Participants will be told if any tests show a medical problem. * If a participant is eligible and decides to join an investigational clinical trial, researchers will explain the study and the risks involved. Participants will sign a separate consent for that clinical trial.
Primary Outcome
A pool of subjects qualified to participate in clinical trials.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2023-04-24 |
| Est. Completion | 2025-05-15 |
What the finished NCT02242968 record still lists
NCT02242968 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 9 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02242968 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02242968 about?
NCT02242968 is a clinical study titled "Screening of Volunteers for Clinical Trials of Investigational or Licensed Vaccines or Antiviral Products". Background: \- Vaccines and antiviral therapies help prevent and treat diseases. Researchers need a group of healthy volunteers for clinical trials. Clinical trials are studies that test these vaccines and therapies in people. Objective: \- To screen volunteers for clinical trials for investigati...
What is the current status of trial NCT02242968?
This trial is currently completed. The enrollment target is 9 participants. The study started on 2023-04-24. Estimated completion is 2025-05-15.
Who is sponsoring clinical trial NCT02242968?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI